Jesus Juárez-Brambila

Jesus Juárez-Brambila, BS, MS, PhD, is an accomplished professional with extensive experience in analytical development and research within the chemical, biotechnology, and pharmaceutical industries. Currently serving as Associate Director of Analytical Development at Axsome Therapeutics, Inc., Jesus also leads Juarez Consulting Group, providing expert services to the industry. Previous roles include Senior Analytical Chemist at Cambrex and various contract positions focusing on analytical method validation and development at Roche, Nektar Therapeutics, and Patheon. Jesus's significant contributions span from drug substance synthesis at BioCryst Pharmaceuticals to groundbreaking research at Avanti Polar Lipids and the University of Alabama. With a PhD in Synthetic Organic Chemistry from the University of California, Santa Cruz, and additional degrees from California State University, Fresno, and Universidad de Guadalajara, Jesus combines a robust educational background with a rich professional history.